ENX-104

Antibiotic compound

ENX-104
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

ENX-104 is a novel antibiotic compound that belongs to the class of beta-lactam antibiotics. It is currently under investigation for its potential use in treating infections caused by Gram-negative bacteria.

Mechanism of Action

ENX-104 functions by inhibiting bacterial cell wall synthesis. Like other beta-lactam antibiotics, it targets the penicillin-binding proteins (PBPs) that are essential for the cross-linking of the peptidoglycan layer in bacterial cell walls. This inhibition leads to cell lysis and death of the bacteria.

Spectrum of Activity

ENX-104 has shown activity against a broad range of Gram-negative bacteria, including strains that are resistant to other antibiotics. It is particularly effective against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.

Development and Clinical Trials

ENX-104 is currently in the early stages of clinical development. Preclinical studies have demonstrated its efficacy in vitro and in animal models. Clinical trials are being conducted to evaluate its safety, tolerability, and efficacy in humans.

Potential Applications

The development of ENX-104 is particularly significant in the context of increasing antibiotic resistance. It offers a potential new treatment option for infections that are difficult to treat with existing antibiotics. ENX-104 could be used in hospital settings for severe infections, especially in patients with compromised immune systems.

Challenges and Considerations

While ENX-104 shows promise, there are challenges in its development. These include ensuring its stability, optimizing its pharmacokinetic properties, and minimizing potential side effects. Additionally, the emergence of resistance to ENX-104 itself is a concern that needs to be addressed through careful monitoring and stewardship.

Related pages

• Antibiotic resistance
• Beta-lactam antibiotics
• Gram-negative bacteria